Ethics Approval
This single-center, parallel-group, randomized controlled study was approved by the University of California San Francisco (UCSF) Institutional Review Board (number 20-32636) and research ethics board and registered on ClinicalTrials.gov (NCT04636528) on November 19, 2020. Treatment and follow-up occurred between March 25, 2021, and December 15, 2022.